← Back to Search

Behavioral Intervention

ActiveHeal for Stress Management

N/A
Recruiting
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be 18-75 years old
Must score 80 to 90 on the Karnofsky Performance Status Scale (KPSS)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 7-8; week 21-22
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to measure the impact of the ActiveHeal EST Program on occupational resilience, health status (quality of life and psychological wellbeing), and its feasibility and acceptability for breast and prostate cancer survivors

Who is the study for?
Adults aged 18-75 diagnosed with prostate or breast cancer within the last 6 months and scoring 80-90 on the KPSS, which measures their ability to carry out daily activities. They must be able to attend sessions at the University of Arkansas for Medical Sciences in Fayetteville.
What is being tested?
The trial is testing ActiveHeal EST Program's impact on occupational resilience, quality of life, and psychological wellbeing among breast and prostate cancer survivors. It also assesses if this program is a practical option for these individuals.
What are the potential side effects?
Since ActiveHeal EST is not a drug but a theoretical framework program aimed at improving well-being, traditional side effects are not applicable. However, participants may experience varying levels of engagement or emotional responses.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 75 years old.
Select...
I am mostly independent but may need help with some activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 7-8; week 21-22
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 7-8; week 21-22 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Occupational Resilience Measure (ORM 1.0)
Secondary study objectives
Psychological Wellbeing Scale
World Health Organization Quality of Life Scale (WHOQOL-BREF)
Other study objectives
Acceptability of Intervention Measure- Experiment Group only
Feasibility of Intervention Measure- Experiment Group only

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
496 Previous Clinical Trials
150,351 Total Patients Enrolled
2 Trials studying Prostate Cancer
85 Patients Enrolled for Prostate Cancer
U of AUNKNOWN
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top